Erythromycin Estolate
Erythromycin Estolate 1GM of
What is Erythromycin Estolate?
Erythromycin Estolate is a macrolide antibiotic derived from Streptomyces erythreus, used primarily to treat a wide range of bacterial infections including respiratory tract, skin, and soft tissue infections. It functions by inhibiting bacterial protein synthesis, thereby stopping bacterial growth. Erythromycin Estolate is known for its improved acid stability and higher serum concentration levels compared to other forms of erythromycin.
Side Effects
- Nausea
- Vomiting
- Abdominal pain
Warnings
- May cause hepatotoxicity; monitor liver function with long-term use.
- Risk of pseudomembranous colitis; monitor for severe or prolonged diarrhea.
- Contraindicated in patients with pre-existing liver disease.
- Avoid use during or two weeks after discontinuing CYP3A4 inhibitors.
- Potential QT prolongation; monitor EKG in patients with heart diseases or electrolyte disturbances.
See your results below for :
Erythromycin Estolate 1GM of
:
Bottle - 20
Erythromycin Estolate Coupons & Prices
What is Erythromycin Estolate ?
Erythromycin Estolate is a macrolide antibiotic derived from Streptomyces erythreus, used primarily to treat a wide range of bacterial infections including respiratory tract, skin, and soft tissue infections. It functions by inhibiting bacterial protein synthesis, thereby stopping bacterial growth. Erythromycin Estolate is known for its improved acid stability and higher serum concentration levels compared to other forms of erythromycin.
Need a Prescription or Refill?
Affordable, same-day video appointments for prescriptions or refills from licensed healthcare providers on your schedule. HSA & FSA-eligible.
Same-day video visit. Sent to your pharmacy.
Erythromycin Estolate
Consumer Forms
Consumer Routes
Therapeutic Classes
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Loss of appetite
- Skin rash
- Jaundice
- May cause hepatotoxicity; monitor liver function with long-term use.
- Risk of pseudomembranous colitis; monitor for severe or prolonged diarrhea.
- Contraindicated in patients with pre-existing liver disease.
- Avoid use during or two weeks after discontinuing CYP3A4 inhibitors.
- Potential QT prolongation; monitor EKG in patients with heart diseases or electrolyte disturbances.
- May interact with drugs metabolized by CYP3A4; check for possible drug interactions.